This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Leder, A N Articles by Shoenfeld, Y Search for Related Content PubMed PubMed Citation Articles by Leder, A N Articles by Shoenfeld, Y Social Bookmarking                   What's this?

Antiphospholipid syndrome induced by HIV

B Flansbaum

Division of Medicine, Long Island Jewish Medical Center, New York, USA

G Zandman-Goddard

Center for Autoimmune Diseases, Department of Medicine ‘B’, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

R Asherson

Rheumatic Diseases Unit, Department of Medicine, The University of Cape Town School of Medicine and The Groote Schuur Hospital, Cape Town, South Africa

Y Shoenfeld

Center for Autoimmune Diseases, Department of Medicine ‘B’, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

A 24-y-old male who developed necrotic lesions on the lower extremities together with testicular thrombosis necessitating orchiectomy, demonstrated high level IgG anticardiolipin (aCL) associated with acute HIV infection. This is one of the first cases describing a close relationship between viral infection and the classic antiphospholipid syndrome (APS). It is well documented that HIV patients may produce antiphospholipid antibodies (aPL), but the full-blown picture of the APS is distinctly uncommon with HIV or any other viral infection, possibly due to the overproduction of the IgM isotype rather than IgG aCL as in this case. The induction of thrombosis following infections has been well described in patients with catastrophic antiphospholipid syndrome (CAPS) but not in patients with the ‘classic or simple’ APS.

Key Words: HIV • antiphospholipid syndrome • anti-cardiolipin • autoimmunity

Lupus, Vol. 10, No. 5, 370-374 (2001)
DOI: 10.1191/096120301669209574


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				U. A. Walker, A. Tyndall, and T. Daikeler Rheumatic conditions in human immunodeficiency virus infection Rheumatology, July 1, 2008; 47(7): 952 - 959. [Abstract] [Full Text] [PDF]

				Y Levy, O Almog, A Gorshtein, and Y Shoenfeld The environment and antiphospholipid syndrome Lupus, November 1, 2006; 15(11): 784 - 790. [Abstract] [PDF]

				I Uthman, I Salti, and M Khamashta Endocrinologic Manifestations of the Antiphospholipid Syndrome Lupus, August 1, 2006; 15(8): 485 - 489. [Abstract] [PDF]

				R Cervera, R A Asherson, M L Acevedo, J A Gomez-Puerta, G Espinosa, G de la Red, V Gil, M Ramos-Casals, M Garcia-Carrasco, M Ingelmo, et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients Ann Rheum Dis, October 1, 2004; 63(10): 1312 - 1317. [Abstract] [Full Text] [PDF]

				R A Asherson and R Cervera Antiphospholipid antibodies and infections Ann Rheum Dis, May 1, 2003; 62(5): 388 - 393. [Abstract] [Full Text] [PDF]